By contrast, the number of patients in the high‐vWF group receiving anticoagulant therapy was higher than that in the low‐vWF group (36 [78%] versus 27 [62%]), although this did not reach statistical significance ( P =0.079) (Table 2 ).
← all excerpts
Von Willebrand Factor Antigen Levels Predict Poor Outcomes in Patients With Stroke and Cancer: Findings From the Multicenter, Prospective, Observational SCAN Study.
1
0.0790
0.0790